AI assistant
Smith & Nephew PLC — Remuneration Information 2019
Feb 8, 2019
4588_dirs_2019-02-08_04fc0006-789d-4bd7-b412-52edc2ddb837.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4915P
Smith & Nephew Plc
08 February 2019
SMITH & NEPHEW PLC
8 February 2019
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.
Smith & Nephew Global Share Plan 2010 (Performance Share Awards):
| Name of PDMR | Number of ordinary shares under award granted on 07/03/2016 (shown at maximum) | Number of ordinary shares lapsed under award (shown at maximum) |
| Rodrigo Bianchi | 46,754 | 25,014 |
| Bradley Cannon | 28,302 | 15,142 |
| Massimiliano Colella | 19,706 | 10,543 |
| Phil Cowdy | 16,570 | 8,865 |
| Elga Lohler | 25,676 | 13,737 |
| Cathy O'Rourke | 13,242 | 7,085 |
| Susan Swabey | 11,794 | 6,310 |
| Glenn Warner | 38,724 | 20,718 |
Notes:
(i) Following completion of the performance measurement period, 93% of the target awards made on 7 March 2016 vested.
(ii) At maximum, 53.5% of awards have lapsed and the remaining 46.5% of awards will vest and subject to continued employment, will be settled on 7 March 2019 being the third anniversary of the awards.
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: 01923 477216
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLIFLAFTITIIA